Adam Taich, EVP Life Sciences, promoted to interim CEO with a focus on operational executionBoard transition adds industry veterans: Jason Ryan as Chairman; Tycho Peterson, Kathy Hibbs, and Tom. | March 28, 2023
28.03.2023 - Adam Taich, EVP Life Sciences, promoted to interim CEO with a focus on operational executionBoard transition adds industry veterans: Jason Ryan as Chairman; Tycho Peterson, Kathy Hibbs, and Tom Carey as Independent DirectorsFourth quarter 2022 .
In a recent study posted to the medRxiv preprint server, researchers at the University of California, San Francisco, and Monogram Biosciences examined the connections between the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) and Epstein-Barr virus (EBV) reactivation.
Cardiopulmonary exercise testing may help identify the underlying mechanism behind persistent symptoms in some patients with postacute sequelae of COVID-19, a study suggests.
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- to 30-fold across